1 / 7
文档名称:

奥拉西坦联合疏血通治疗原发性脑出血的临床研究.doc

格式:doc   页数:7
下载后只包含 1 个 DOC 格式的文档,没有任何的图纸或源代码,查看文件列表

如果您已付费下载过本站文档,您可以点这里二次下载

分享

预览

奥拉西坦联合疏血通治疗原发性脑出血的临床研究.doc

上传人:豆芽 2014/2/3 文件大小:0 KB

下载得到文件列表

奥拉西坦联合疏血通治疗原发性脑出血的临床研究.doc

文档介绍

文档介绍:奥拉西坦联合疏血通治疗原发性脑出血的临床研究
(作者:___________单位: ___________邮编: ___________)
【摘要】目的探讨奥拉西坦联合疏血通治疗原发性脑出血的临床疗效。方法将80例患者随机分为两组,治疗组44例,加用奥拉西坦和疏血通静脉滴注;对照组33例,加用胞磷胆碱钠静脉滴注,疗程均为21 d。以NIHSS计分评定神经功能缺失,以MMSE计分评定认知功能障碍,分析比较两组的治疗效果。结果治疗组NIHSS评分和MMSE评分与治疗前相比较P<;与对照组相比较P<。其疗效优于对照组。结论奥拉西坦联合疏血通治疗原发性脑出血疗效满意。
【关键词】原发性脑出血;奥拉西坦;疏血通
【Abstract】 Objective To investigate the therapeutic efficacy of bined with shuxuetong in patients with primary intracranial Eighty cases with primary intracranial hemorrhages were randomly divided into two groups:44 cases were treated with bined with shuxuetong by intravenous infusing for 21days;36 cases were the conrtol group treated with citicoline sodium by intravenous infusing for 21days. To evaluate neural dysfunction with the scores of NIHSS and cognitive dysfunction with the scores of MMSE. To analyze the therapeutic pared with the control group. Results In these two groups, all of the scores of NIHSS and MMSE after the therapy were better than those before the therapy. And there was statistical significance difference (P<) .The scores of NIHSS and MMSE and MMSE after the therapy were better in therapeutic group than those in the control group .And there was statistical significance difference between the two groups (P<) .Conclusion The therapeutic efficacy of bined with shuxuetong in treating patients with primary intracranial h